Physician profile

Aaron Kunamalla

Cardiovascular Disease · Boston, MA

NPI 1477087872

$85,522.01

in general payments reported to CMS, 2019-2025

17 companies · $745 in 2025

The $745 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Grant$80,000.00
Food and Beverage$3,123.10
Travel and Lodging$1,612.30
Education$162.49

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Edwards Lifesciences Corporation $50,606.01 2022-2025 Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia
Boston Scientific Corporation $30,426.38 2021-2024 Avvigo Guidance System, Stingray, Comet
Abbott Laboratories $3,280.50 2022-2025 Mitraclip, Portico, Triclip
Abiomed $440.79 2024 Impella
Medtronic, INC. $166.68 2024 Onyx Frontier, Corevalve Evolut R
Novo Nordisk INC $124.67 2023
Terumo Medical Corporation $117.57 2020-2022
Cardiovascular Systems INC. $69.07 2021
Teleflex LLC $58.84 2021-2023 Supercross
Philips North America LLC $40.87 2024 (Bq9) Coronary Ivus
Opsens INC. $38.72 2023 Optowire
Acist Medical Systems, INC. $30.18 2024
Novartis Pharmaceuticals Corporation $28.57 2023
Livanova USA, INC. $28.19 2022
Zoll Circulation INC $25.00 2023 Therox Ds2 Console, Catheter, Downstream Cartridge
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Shockwave Medical, INC $20.44 2021
Cordis US Corp. $19.53 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Aaron Kunamalla

$85,522.01

in general payments reported 2019-2025

Years
2020-2025
Top company
Edwards Lifesciences Corporation
Context
The $745 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/8558161/aaron-kunamalla

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.